Boardroom Alpha
Research library
SPACs · Oct 21, 2026

SPAC Market Update October 21, 2026: TRAD to Merge with Korai Flix, SSEA Extension Redemptions

Apex Tech Acquisition Inc (TRAD) announced a merger with Korai Flix Inc, a South Korea-headquartered AI-powered interactive entertainment platform, on October 21, 2026; no transaction dollar value was disclosed. Separately, Starry Sea Acquisition Corp (SSEA)…

SPAC IPO Update — October 21, 2026

No SPAC IPOs priced on October 21, 2026; October MTD now stands at 4 IPOs totaling $491M over 21 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 4 IPOs ($491M) vs. first 21 days of last month 3 ($538M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 16 TCXB TCGX ACQUISITION CORP II $100M 100.0%
Oct 14 FLSC FRAZIER LIFE SCIENCES ACQUISITION CORP II $75M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 21, 2026

SPAC VOTE RESULTS
STARRY SEA ACQUISITION CORP (SSEA) * Extend to November 7, 20273,895,270 redeemed
HEALTHCARE AI ACQUISITION CORP (HAIA) * Extend to October 14, 2027
ASPAC III ACQUISITION CORP (ASPC) * Extend to November 12, 20288,093 redeemed

SPAC DEALS ANNOUNCED
October 21 | Apex Tech Acquisition Inc (TRAD) + Korai Flix IncKorai Flix Inc is an interactive online entertainment platform headquartered in South Korea. It offers AI-powered interactive content experiences, including AI short dramas and AI companion avatars. The platform serves a growing user base across Asia, providing personalized and immersive entertainment experiences.
October 19 | Tcgx Acquisition Corp (TCGX) + TriGemX BioTriGemX Bio is a biotechnology company developing elismetrep, a potential first-in-class TRPM8 channel blocker aimed at treating migraines. The company’s research focuses on neural signaling pathways, particularly targeting the trigeminal ganglion, where TRPM8 is expressed. Elismetrep is currently undergoing Phase 3 trials for acute migraine treatment, with initial results expected in mid-2027.

SPAC EXTENSIONS
QUARTZSEA ACQUISITION CORP (QSEA) * Extension FilingQuartzsea Acquisition extended its deadline for a business combination by one month via a $100,000 trust deposit.

SEPARATE WARRANTS/RIGHTS
October 23: PINE TREE ACQUISITION CORP (PAXG)

OTHER SPAC NEWS
APEX TECH ACQUISITION INC (TRAD) * Merger Agreement
BOLD EAGLE ACQUISITION CORP (BEAG) * S-4 FiledBold Eagle and REDLattice filed a draft Form S-4 for their business combination, with a press release issued.
CHURCHILL CAPITAL CORP XI (CCXI) * Media TranscriptAgility discusses Digit 5 safety advances and business model amid Churchill XI merger talks. Highlights include safety features, service model, and demand signals.

SPAC Movers — October 21, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RF ACQUISITION CORP II RFAI 4.6% $ 31.88 Announced
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
BLACK HAWK ACQUISITION CORP BKHA 2.7% $ 4.14 Announced
SILVERBOX CORP IV SBXD 2.6% $ 11.39 Announced
JATT III ACQUISITION CORP JTTT 1.7% $ 10.35 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
ARCHIMEDES TECH SPAC PARTNERS II CO ATII -16.1% $ 7.17 Announced
RIBBON ACQUISITION CORP RIBB -3.2% $ 6.00 Announced
RESEARCH ALLIANCE CORP IV RACD -2.8% $ 10.37 Pre-Deal
AIMEI HEALTH TECHNOLOGY CO LTD AFJK -1.4% $ 12.10 Pre-Deal
CHURCHILL CAPITAL CORP XI CCXI -1.2% $ 10.36 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What did Apex Tech Acquisition announce on October 21, 2026?
    Apex Tech Acquisition Inc (TRAD) announced a merger with Korai Flix Inc, an interactive online entertainment platform headquartered in South Korea that offers AI short dramas and AI companion avatars.
  • Which extension approval had the largest reported redemptions today?
    Starry Sea Acquisition Corp (SSEA) had 3,895,270 shares redeemed and extended its deadline to November 7, 2027. Its listed target is SuperiorMed Holdings Limited.
  • Which other extension approvals were reported today?
    Healthcare AI Acquisition Corp (HAIA) extended its deadline to October 14, 2027, and ASPAC III Acquisition Corp (ASPC) extended its deadline to November 12, 2028 with 8,093 shares redeemed.
  • How many SPAC IPOs priced in October 2026 through October 21?
    4 SPAC IPOs priced for $491M through 21 sessions in October 2026, including over-allotment, compared with 3 IPOs for $538M over the same span last month.
  • Did any new SPAC IPO price on October 21, 2026?
    No SPAC IPO priced on October 21, 2026. Month-to-date issuance was 4 IPOs for $491M through 21 sessions.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 21, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer